The MAGE-A1 gene expression is not determined solely by methylation status of the promoter region in hematological malignancies

Leukemia Research

Volumn 26, Issue 12, 2002, Pages 1113-1118

  Suyama, Takahiro ^a   Ohashi, Haruhiko ^b   Nagai, Hirokazu ^b   Hatano, Sonoko ^a   Asano, Haruhiko ^a   Murate, Takashi ^c   Saito, Hidehiko ^a,b   Kinoshita, Tomohiro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Aberrant demethylation; Cancer testis antigen; Human hematological malignancy; MAGE A1

Indexed keywords

BISULFITE; TUMOR ANTIGEN;

ARTICLE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE MAPPING; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036889949     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00048-6     Document Type: Article

References (20)

1. Renkvist N., Castelli C., Robbins P.F., Parmiani G. A listing of human tumor antigens recognized by T-cells. Cancer Immunol Immunother. 50:2001;3-15.
2. Jassim A., Ollier W., Payne A., Biro A., Oliver R.T., Festenstein H. Analysis of HLA antigens on germ cells in human semen. Eur J Immunol. 19:1989;1215-1220.
3. Marchand M., van Baren N., Weynants P., Brichard V., Dreno B., Tessier M.H.et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer. 80:1999;219.
4. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B.et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1991;1643-1647.
5. Traversari C., van der Bruggen P., Luescher I.F., Lurquin C., Chomez P., Van Pel A.et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med. 176:1992;1453-1457.
6. De Plaen E., Arden K., Traversari C., Graforio J.J., De Smet C., Szikora J.-P.et al. Structure, chromosomal localization and expression of 12 genes of MAGE family. Immunogenetics. 40:1994;360-369.
7. Baren N.V., Brasseur F., Thielemans K., Boon T. Gene encoding tumor-specific antigens are expressed in human Myeloma cells. Blood. 94:1999;1156-1164.
8. Shichijo S., Tsunosue R., Masuoka K., Natori H., Tamai M., Miyajima J.et al. Expression of the MAGE gene family in human lymphocytic leukemia. Cancer Immunol Immunother. 41:1995;95-103.
9. Shichijo S., Sagawa K., Brasseur F., Boon T., Itoh K. MAGE-1 gene is expressed in T-cell leukemia. Int J Cancer. 65:1996;709-710.
10. Chambost H., Baren N.V., Brasseur F., Godelaine D., Xeri L., Landi S.J.et al. Expression of gene MAGE-A4 in Reed-Sternberg cells. Blood. 95:2000;3530-3533.
11. Baylin S.B., Herman J.G., Graff J.R., Vertino P.M., Issa J.P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 72:1998;141-196.
12. INK4B gene in myelodysplastic syndromes. Blood. 90:1997;1403-1409.
13. Hanada M., Delia D., Aiello A., Stadtmauer E., Reed J.C. BCL-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood. 82:1993;1820-1828.
14. De Smet C, Stephane J, Courtois, Faraoni I, Lurquin C, Szikora JP, Olivier, De Backer, Boon T. Involvement of two Ets binding sites in the transcriptional activation of the MAGE-1 gene. Immunogenetic, 1995;42:282-90.
15. De Smet C., Lurquin C., Lethe B., Martelange V., Boon T. DNA Methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol. 19:1999;7327-7335.
16. Ohashi H., Hotta T., Ichikawa A., Kinoshita T., Taguchi R., Kiguchi T.et al. Peripheral blood cells are predominantly chimeric of affected and normal cells in patients with paroxysmal nocturnal hemoglobinuria: simultaneous investigation on clonality and expression of glycophosphatidylinositol-anchored proteins. Blood. 83:1994;853-859.
17. Kinoshita T., Shimoyama M., Tobinai K., Itoh M., Itoh S., Ikeda S.et al. Detection of mRNA for tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci USA. 86:1989;5620-5624.
18. Herman J.G., Graff J.R., Myöhänsen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 93:1996;9821-9826.
19. Chambost H., Brasseur F., Coulie P., De Plaen E., Stoppa A.M., Baume D.et al. A tumor-associated antigen expression in human haematological malignancies. Br J Haematol. 84:1993;524-526.
20. De Smet C., De Backer O., Faraoni I., Lurquin C., Brasseur F., Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA. 93:1996;7149-7153.